Kintayl Capital »

Terns Pharmaceuticals shares owned by Kintayl Capital

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Kintayl Capital from 13F filings

Historical chart of Kintayl Capital investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Kintayl Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Kintayl Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 29k 52.72

More positions owned by Kintayl Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Essential Utils (WTRG)
Qorvo (QRVO)
Northwestern Energy Group In Com New (NWE)
Kenvue (KVUE)
Liberty Broadband Corp Com Ser C (LBRDK)
Ncr Atleos Corporation Com Shs (NATL)
Webster Financial Corporation (WBS)
Norfolk Southern (NSC)
AES Corporation (AES)
Valaris Cl A (VAL)
Electronic Arts (EA)
Riot Blockchain (RIOT)
Allied Gold Corp Com New (AAUC)
Warner Bros Discovery Com Ser A (WBD)

View all positions for Kintayl Capital

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals